Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00494169 · ClinicalTrials.gov registry record
Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 4,042
- Enrollment target
NCT00494169: Completed study, sponsored by Massachusetts General Hospital.
NCT00494169 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 4,042 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00494169 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 4,042 participants
- Enrollment target
Study Summary
The aims of this study are: 1) to identify genes that play a role in human pubertal development and reproduction, 2) to characterize the phenotypic spectrum of patients with these gene defects, and 3) to discern the mode of inheritance for disorders caused by these gene defects. We are specifically interested in genes that cause Kallmann syndrome, idiopathic hypogonadotropic hypogonadism (IHH), precocious (early) puberty, and delayed puberty. Individuals do not have to travel to Boston to participate in this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,042 participants |
| Start Date | 1999-01 |
| Est. Completion | 2022-02 |
What the finished NCT00494169 record still lists
NCT00494169 is an observational study that tracks outcomes without assigning an intervention. Its 4,042 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00494169 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00494169 about?
NCT00494169 is a clinical study titled "Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders". The aims of this study are: 1) to identify genes that play a role in human pubertal development and reproduction, 2) to characterize the phenotypic spectrum of patients with these gene defects, and 3) to discern the mode of inheritance for disorders caused by these gene defects. We are specifically ...
What is the current status of trial NCT00494169?
This trial is currently completed. The enrollment target is 4,042 participants. The study started on 1999-01. Estimated completion is 2022-02.
Who is sponsoring clinical trial NCT00494169?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia